Cellumed Co.,Ltd. Statistics

Total Valuation

Cellumed Co.,Ltd. has a market cap or net worth of KRW 105.59 billion. The enterprise value is 111.13 billion.

Market Cap	105.59B
Enterprise Value	111.13B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellumed Co.,Ltd. has 51.51 million shares outstanding. The number of shares has increased by 11.14% in one year.

Current Share Class	n/a
Shares Outstanding	51.51M
Shares Change (YoY)	+11.14%
Shares Change (QoQ)	-0.86%
Owned by Insiders (%)	3.31%
Owned by Institutions (%)	0.08%
Float	35.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.80
PB Ratio	3.23
P/TBV Ratio	3.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.59
EV / Sales	0.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-22.49

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.30.

Current Ratio	1.38
Quick Ratio	0.60
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-2.03
Interest Coverage	-9.66

Financial Efficiency

Return on equity (ROE) is -77.33% and return on invested capital (ROIC) is -19.25%.

Return on Equity (ROE)	-77.33%
Return on Assets (ROA)	-11.87%
Return on Capital (ROIC)	-19.25%
Revenue Per Employee	1.34B
Profits Per Employee	-347.42M
Employee Count	89
Asset Turnover	1.41
Inventory Turnover	13.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.29%
50-Day Moving Average	2,553.52
200-Day Moving Average	2,056.57
Relative Strength Index (RSI)	39.48
Average Volume (20 Days)	696,322

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellumed Co.,Ltd. had revenue of KRW 119.64 billion and -30.92 billion in losses. Loss per share was -661.25.

Revenue	119.64B
Gross Profit	10.68B
Operating Income	-16.16B
Pretax Income	-31.98B
Net Income	-30.92B
EBITDA	-14.56B
EBIT	-16.16B
Loss Per Share	-661.25

Full Income Statement

Balance Sheet

The company has 5.01 billion in cash and 10.01 billion in debt, giving a net cash position of -5.00 billion or -97.13 per share.

Cash & Cash Equivalents	5.01B
Total Debt	10.01B
Net Cash	-5.00B
Net Cash Per Share	-97.13
Equity (Book Value)	32.90B
Book Value Per Share	633.94
Working Capital	14.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.14 billion and capital expenditures -1.80 billion, giving a free cash flow of -4.94 billion.

Operating Cash Flow	-3.14B
Capital Expenditures	-1.80B
Free Cash Flow	-4.94B
FCF Per Share	-95.96

Full Cash Flow Statement

Margins

Gross margin is 8.93%, with operating and profit margins of -13.50% and -25.84%.

Gross Margin	8.93%
Operating Margin	-13.50%
Pretax Margin	-26.73%
Profit Margin	-25.84%
EBITDA Margin	-12.17%
EBIT Margin	-13.50%
FCF Margin	n/a

Dividends & Yields

Cellumed Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.14%
Shareholder Yield	-11.14%
Earnings Yield	-32.26%
FCF Yield	-4.68%

Stock Splits

The last stock split was on April 28, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 28, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

Cellumed Co.,Ltd. has an Altman Z-Score of 0.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.27
Piotroski F-Score	n/a